Infinimmune
Andrew Hill is a skilled computational biologist with extensive experience in genomic research and product development. Currently serving as a Scientist in Computational Biology at Infinimmune since December 2023, Andrew previously held the position of Senior Computational Biologist at Tune Therapeutics, where contributions included R&D for epigenome editing technologies and co-leading experimental designs for various screens. Prior to that, Andrew worked at 10x Genomics, engaging in early-stage R&D for spatial and single-cell genomics and collaborating across multidisciplinary teams. Andrew earned a Ph.D. in Genome Sciences and a B.Sc. in Bioengineering from the University of Washington, where early research experience encompassed image processing, machine learning, and experimental design related to soft tissue dynamics.
This person is not in any teams
This person is not in any offices